JY
STML

Jeff Yass’s Stemline Therapeutics, Inc. STML Stock Holding History

Jeff Yass’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,200
Closed -$130K – 11247
2019
Q4 		$130K Sell
12,200
-14,000
-53% -$139K ﹤0.01% 9020
2019
Q3 		$273K Sell
26,200
-18,400
-41% -$241K ﹤0.01% 8505
2019
Q2 		$683K Buy
44,600
+18,200
+69% +$263K ﹤0.01% 6569
2019
Q1 		$339K Buy
+26,400
New +$298K ﹤0.01% 7007
2018
Q4 		– Sell
-14,200
Closed -$236K – 10436
2018
Q3 		$236K Sell
14,200
-1,400
-9% -$22.4K ﹤0.01% 7935
2018
Q2 		$250K Sell
15,600
-2,900
-16% -$51.8K ﹤0.01% 8189
2018
Q1 		$283K Sell
18,500
-7,100
-28% -$111K ﹤0.01% 7725
2017
Q4 		$399K Buy
25,600
+9,200
+56% +$123K ﹤0.01% 7063
2017
Q3 		$182K Sell
16,400
-48,300
-75% -$454K ﹤0.01% 8084
2017
Q2 		$595K Buy
64,700
+1,500
+2% +$12.5K ﹤0.01% 6315
2017
Q1 		$540K Buy
+63,200
New +$576K ﹤0.01% 6341

Jeff Yass's STML Position: Q2 2020 in Review

Jeff Yass sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 59,168 shares — an estimated $286K sold.

Jeff Yass first reported a position in STML in Q4 2013 and held it in 19 quarters. The position peaked at $1.85M in Q4 2018. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Jeff Yass reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Jeff Yass sold 59,168 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $286K.
  • Jeff Yass first reported a position in Stemline Therapeutics, Inc. in Q4 2013 and held it in 19 quarters.
  • Jeff Yass's Stemline Therapeutics, Inc. position peaked at $1.85M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.